Melrio Cream is a topical formulation combining Hydroquinone (20 mg), Tretinoin (0.25 mg), and Fluocinolone Acetonide (0.5 mg), indicated primarily for the treatment of melasma and other hyperpigmentation disorders. Hydroquinone acts as a depigmenting agent by inhibiting tyrosinase, thereby reducing melanin synthesis and lightening hyperpigmented areas. Tretinoin, a retinoid, promotes epidermal cell turnover and enhances the penetration of hydroquinone, facilitating more effective pigment reduction while also improving skin texture. Fluocinolone acetonide, a potent corticosteroid, provides anti-inflammatory effects that help mitigate irritation commonly associated with hydroquinone and tretinoin use, improving patient tolerability. Melrio Cream should be applied once daily, preferably at night, to clean, dry skin on affected areas. Patients are advised to avoid excessive sun exposure and use broad-spectrum sunscreen during treatment to prevent further pigmentation. Common adverse effects may include mild erythema, peeling, or dryness; however, prolonged use of corticosteroids should be monitored to avoid potential side effects such as skin atrophy. This combination therapy offers a synergistic approach for effective management of hyperpigmentation, but should be used under medical supervision to optimize outcomes and minimize risks.